CAS RN: 111321-67-6

Dihydroxy Oxaliplatin-Pt(IV)

Product Availability

Choose a grade to view its available package options.

4 package records2 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260608 100mg In stock Shanghai Inquiry
Batchno.20250304 1g Out of stock Inquiry
Batchno.20250121 250mg Out of stock Inquiry
Batchno.20260517 50mg In stock Shanghai, Chengdu Inquiry
  • Product code: SSC-012127
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 0.1g
  • Available purity: ≥95%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 111321-67-6
Pack Size Recorded Purity Available Qty Ship From Inquiry
0.1g ≥95% 0 Out of Stock Shanghai Inquiry

111321-67-6 / oxalate;platinum(4+);trans-(1R,2R)-cyclohexane-1,2-diamine;dihydroxide

AXA37HSS7Z | Oxaliplatin specified impurity C [EP] | OXALIPLATIN IMPURITY C [EP IMPURITY]

Standard CAS: 111321-67-6 Multi CAS: Yes

Basic Information

CAS
111321-67-6
Multi CAS
Yes
Molecular Formula
C8H16N2O6Pt
Molecular Weight
431.310000
Exact Mass
431.065631
SMILES
C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)[O-])[O-].[OH-].[OH-].[Pt+4]
InChI
InChI=1S/C6H14N2.C2H2O4.2H2O.Pt/c7-5-3-1-2-4-6(5)8;3-1(4)2(5)6;;;/h5-6H,1-4,7-8H2;(H,3,4)(H,5,6);2*1H2;/q;;;;+4/p-4/t5-,6-;;;;/m1..../s1
InChIKey
CRUOOYJLGQUXMM-NDSUJOINSA-J
Synonyms
AXA37HSS7Z Oxaliplatin specified impurity C [EP] OXALIPLATIN IMPURITY C [EP IMPURITY] ((1R-trans-(1,2-Cyclohexanediamine-N,N'))-trans-dihydroxido-(oxalato(2-)-O,O')platinum(IV)) (OC-6-33)-((1R,2R)-CYCLOHEXANE-1,2-DIAMINE.KAPPA.N,.KAPPA.N')(ETHANEDIOATO(2-)-.KAPPA.O1,.KAPPA.O2)DIHYDROXYPLATINUM

Computed Properties

Structural Parameters

Heavy atom count
17
Fraction Csp3
0.75
H-bond acceptors
8
H-bond donors
2
Molar refractivity
48.3
TPSA
192.3

LogP / Solubility

WLOGP
-3.65
MLOGP
-3.19
XLogP3
-3.65
Consensus LogP
-3.5
Log S (ESOL)
-0.21
Class (ESOL)
Very soluble
Log S (Ali)
-0.46
Class (Ali)
Very soluble
Log S (SILICOS-IT)
0.57
Class (SILICOS-IT)
Highly soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-7.95

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
2.5

Safety & Transport

Pictogram(s)
Acute Toxic Irritant Health Hazard
Signal
Danger
GHS Hazard Statements
H302 (95.8%): Harmful if swallowed [Warning Acute toxicity, oral] H311+H331 (91.7%): Toxic in contact with skin or if inhaled. [Danger Acute toxicity, dermal; acute toxicity, inhalation] H311 (100%): Toxic in contact with skin [Danger Acute toxicity, dermal] H317 (95.8%): May cause an allergic skin reaction [Warning Sensitization, Skin] H331 (100%): Toxic if inhaled [Danger Acute toxicity, inhalation]
Precautionary Statement Codes
P203, P233, P260, P261, P262, P263, P264, P270, P271, P272, P280, P284, P301+P317, P302+P352, P304+P340, P316, P318, P321, P330, P333+P317, P342+P316, P361+P364, P362+P364, P403, P403+P233, P405, and P501

Get In Touch

Contact Us